GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (XTAE:ORMP) » Definitions » FCF Yield %

Oramed Pharmaceuticals (XTAE:ORMP) FCF Yield % : -8.93 (As of Apr. 25, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Oramed Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Oramed Pharmaceuticals's Trailing 12-Month Free Cash Flow is ₪-30.54 Mil, and Market Cap is ₪347.84 Mil. Therefore, Oramed Pharmaceuticals's FCF Yield % for today is -8.93%.

The historical rank and industry rank for Oramed Pharmaceuticals's FCF Yield % or its related term are showing as below:

XTAE:ORMP' s FCF Yield % Range Over the Past 10 Years
Min: -37.15   Med: -9.1   Max: 10.63
Current: -8.93


During the past 13 years, the highest FCF Yield % of Oramed Pharmaceuticals was 10.63%. The lowest was -37.15%. And the median was -9.10%.

XTAE:ORMP's FCF Yield % is ranked better than
58.88% of 1498 companies
in the Biotechnology industry
Industry Median: -14.885 vs XTAE:ORMP: -8.93

Oramed Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


Oramed Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Oramed Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals FCF Yield % Chart

Oramed Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23 Dec24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.77 -3.50 -6.70 -11.55 -8.99

Oramed Pharmaceuticals Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.22 -4.96 7.64 -27.56 -8.20

Competitive Comparison of Oramed Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Oramed Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oramed Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's FCF Yield % falls into.


;
;

Oramed Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Oramed Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-30.55 / 339.63936
=-8.99%

Oramed Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.966 * 4 / 339.63936
=-8.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oramed Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Oramed Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oramed Pharmaceuticals Business Description

Traded in Other Exchanges
Address
1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.